Actively Recruiting
Implementation of an Oral Chemotherapy Adherence Intervention
Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2025-07-08
160
Participants Needed
1
Research Sites
170 weeks
Total Duration
On this page
Sponsors
U
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to evaluate the effectiveness and usability of a newly developed oral anticancer agent adherence program implemented across 6 cancer clinics (two academic, two urban, and two rural). The study will include 160 adult participants with either solid tumors or hematologic malignancies who have been taking oral anticancer agents for at least six months. This study will have two groups of participants, a pre- and post-implementation group. In the pre-implementation of the program group, investigators will administer a survey to the 80 participants and gather information about their medication prior to their enrollment of the program. Similarly, 80 participants who have been enrolled into this program for at least 6 months will serve as the post-implementation group. These patients will be administered the same survey. The results from both groups will be analyzed to see how effective the medication adherence program is.
CONDITIONS
Official Title
Implementation of an Oral Chemotherapy Adherence Intervention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult (age 6521 years-old) patients
- Diagnosed with a solid or hematologic malignancy
- Monotherapy on oral anticancer agent on treatment for at least 6 months
You will not qualify if you...
- Patients on time-limited or intermittent therapy (non-continuous)
- Patients on comfort (end-of-life) care
- Patients enrolled on hospice
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UNC Chapel Hill
Chapel Hill, North Carolina, United States, 27516
Actively Recruiting
Research Team
S
Solomon Ayehu, MD
CONTACT
B
Bethel Belayneh
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here